Genetic drivers of human plasma metabolites that determine mortality in heart failure patients with reduced ejection fraction
BackgroundHeart failure with reduced ejection fraction (HFrEF) remains a significant public health issue, with the disease advancing despite neurohormonal antagonism. Energetic dysfunction is a likely contributor to residual disease progression, and we have previously reported a strong association o...
Salvato in:
| Autori principali: | , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2024-07-01
|
| Serie: | Frontiers in Cardiovascular Medicine |
| Soggetti: | |
| Accesso online: | https://www.frontiersin.org/articles/10.3389/fcvm.2024.1409340/full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
